PYRIDINONVERBINDUNGEN

European patent · EP2089364 · In force

Register entry

Publication number
EP2089364
Application number
EP07844974
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 8, 2007
Published
Aug 19, 2009
Granted
Jun 12, 2013
Protection ends at the latest
Nov 7, 2027
Next annual fee due
Nov 30, 2026
IPC classes
C07D 213/82 (2006.01)
A61K 31/444 (2006.01)
A61P 35/00 (2006.01)
Priority
US 857540 P 08.11.2006
PCT application
PCT/US2007/084047 08.11.2007
PCT publication
WO2008/058229 15.05.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Jan 26, 2024

    Change

    Published in Swissreg on 26.01.2024

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Jul 30, 2013

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 30.07.2013

  6. Jun 12, 2013

    Granted

    Published in Swissreg on 12.06.2013

Parties

Holder

Bristol-Myers Squibb Company

Route 206 and Province Line Road, Princeton, NJ 08543-4000, US

Agent

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventor

BORZILLERI, Robert M.

Princeton, NJ 08543, US

SCHROEDER, Gretchen M.

Princeton, NJ 08543, US

CAI, Zhen-wei

Princeton, NJ 08543, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.